D&C BIOTECHNOLOGY
AI-powered urine diagnostics for early disease detection.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| N/A | KRW600m | Grant | |
| Total Funding | 000k | ||
D&C Biotechnology Inc. is a South Korean startup founded in 2021 by CEO Sungsoo Park that develops next-generation in-vitro diagnostic solutions. The company is focused on solving issues of contamination and inconvenience associated with traditional urine testing methods in medical settings. It offers AI-powered, cup-type urine test kits and personal analyzers that enable individuals to monitor their health and detect diseases early from home. The solutions aim to connect users with medical institutions for non-face-to-face services, addressing challenges in medically underserved areas.
The company's core technology is a flexible optical biosensor used in its next-generation urinalysis analyzers, a technology that has received 'New Excellent Technology' (NET) certification. Its product lineup includes 'URINE CHECK-IT' and 'URINE CHECK-ER'. These products have gained international recognition, winning CES Innovation Awards in both 2024 and 2025 and Good Design Awards in 2023 and 2024.
D&C Biotechnology has secured funding through several rounds, including a ₩500 million seed round and a ₩1 billion Pre-Series A round, with total funding reaching $1.17 million. It is backed by investors such as True Innovation, Hallym University Technology Holdings, and the Tech Incubator Program for Startup (TIPS). The company was selected for the 'TIPS' program in 2023 and the prestigious 'Super-Gap Startup 1000+ Project' by the Korean Ministry of SMEs and Startups in 2025, which provides significant funding for commercialization and R&D. D&C Biotechnology is headquartered in Daejeon, South Korea, and is planning to establish a US subsidiary to accelerate its global expansion.
Keywords: urine diagnostics, in-vitro diagnostic, IVD, home healthcare, AI diagnostics, medical device, optical biosensor, urinalysis, CES Innovation Award, health monitoring, preventive healthcare, digital health, Sungsoo Park, medtech, diagnostics solutions, point-of-care testing, remote monitoring, non-invasive diagnostics, chronic disease management, telemedicine